GLP-1 receptor agonists have largely contributed to revolutionising pharmacological therapy of type 2 diabetes. They are among the most potent glucose-lowering agents, while also eliciting bodyweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results